Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

作者：Marina Chiara Garassino, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Giovanna Speranza, Manuel Dómine, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Ziwen Wei, Thomas Burke, M. Catherine Pietanza, Delvys Rodríguez‐Abreu · 发表于：The Lancet Oncology · 年份：2020 · 被引用次数：220 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations、Lung Cancer Diagnosis and Treatment